EXELIXIS, INC. — Director's Dealing 2019

Jan 10, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2019-01-07

Reporting Person: Haley Patrick J. (Sr. Vice President, Commercial)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-07	Common Stock	M	1560	$5.82	Acquired	98571	Direct
2019-01-07	Common Stock	S	1560	$21.50	Disposed	97011	Direct
2019-01-07	Common Stock	M	4000	$1.76	Acquired	101011	Direct
2019-01-07	Common Stock	S	4000	$21.52	Disposed	97011	Direct
2019-01-08	Common Stock	M	2000	$1.76	Acquired	99011	Direct
2019-01-08	Common Stock	S	2000	$23	Disposed	97011	Direct
2019-01-09	Common Stock	M	1560	$5.82	Acquired	98571	Direct
2019-01-09	Common Stock	S	1560	$23.50	Disposed	97011	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-07	Option (right to buy)	$5.82	M	1560	Disposed	2020-09-29	Common Stock (1560.0)	Direct
2019-01-07	Option (right to buy)	$1.76	M	4000	Disposed	2021-11-16	Common Stock (4000.0)	Direct
2019-01-08	Option (right to buy)	$1.76	M	2000	Disposed	2021-11-16	Common Stock (2000.0)	Direct
2019-01-09	Option (right to buy)	$5.82	M	1560	Disposed	2020-09-29	Common Stock (1560.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	23539	Indirect
Common Stock	10283	Indirect

Footnotes

F1: Includes 49,234 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F2: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018.

F3: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.03 to $22.00. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.

F4: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of January 7, 2019.

F5: The option, representing the right to purchase a total of 7,800 shares of Exelixis, Inc. common stock, became fully exercisable on September 30, 2017.

F6: The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on November 17, 2018.